Genomics: Implications for anesthesia, perioperative care and outcomes

Advances in Anesthesia

Volumn 27, Issue 1, 2009, Pages 73-94

  Body, Simon C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861371524     PISSN: 07376146     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.aan.2009.07.006     Document Type: Review

References (8)

1. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3(5):391-7.
2. Eckman MH, Rosand J, Greenberg SM, et al. Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med 2009;150(2):73-83.
3. Center for Medicare and Medicaid Services. Proposed decisionmemofor pharmacogenomic testing for warfarin response (CAG-00400N). Available at: https://www.cms.hhs.gove/mcd/viewdraftdecisionmemo.asp?id1/4224. Accessed August 10, 2009.
4. John EM, Miron A, Gong G, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 2007;298(24):2869-76.
5. National Cancer Institute. BRCA1 and BRCA2: cancer risk and genetic testing. Available at: http://www.cancer.gov/cancertopics/factsheet/risk.brca. Accessed August 10, 2009.
6. Paynter NP, Chasman DI, Buring JE, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009;150(2):65-72.
7. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448(7151):353-7.
8. Body S, Collard C, Shernan S, et al. Variation in the 4q25 chromosomal locus predicts newonset atrial fibrillation after cardiac surgery [abstract]. Circulation 2008;118:S882.